Teaching information for CMA

If you are interested in using CMA to teach a class in meta-analysis, please submit your e-mail here for more information.

Valid e-mail is required.

Please provide the university / organization, the approximate class size, and the course duration below.

Details are required.

"CMA is a formidable tool for conducting sophisticated meta‐analyses in the domain of cognitive and behavioral sciences. As an early adapter of CMA I am still amazed about its flexibility in data storing, data processing, and its many options for validity checks of meta‐analytic outcomes such as trim‐and‐fill and other state‐of‐the‐art ways to test the influence of unpublished papers. The flexibility of CMA to exchange data with Excel, SPSS, and other statistical software is a major asset. I also taught courses on meta‐analysis with the student version of CMA available for the graduate students, and it has been a real success as CMA makes meta‐analysis transparent as well as motivating for students with a basic training in statistics."

Marinus H. van IJzendoorn - Centre for Child and Family Studies, Rommert Casimir Institute of Developmental Psychopathology, Institute of Education and Child Studies, Leiden University, The Netherlands


"The program in Comparative Effectiveness and Outcomes Research at Duke University conducts multiple systematic reviews and meta‐analyses each year for professional organizations as well as under both federal and industry sponsored research initiatives. While we use various programs tailored for specific individual projects including those developed in‐house, we have found Comprehensive Meta‐Analysis (CMA) to be a very facile, adaptable and yet comprehensive package meeting the needs for much of our research and generating publication‐quality graphics. My confidence in the analytic algorithms is buoyed by my knowledge of several of the developers of CMA and based on extensive comparison of results with other algorithms including our own. CMA is also an exceptional educational tool and universally embraced by trainees and young investigators initiating careers in evidence‐based medicine and statistical analysis."

Gary H Lyman, MD, MPH, FRCP (Edin) - Professor of Medicine and Director, Comparative Effectiveness and Outcomes Research, Duke University School of Medicine, and the Duke Comprehensive Cancer Center, Senior Fellow, Duke Center for Clinical Health Policy Research, Durham, NC